WallStreetZenWallStreetZen

NASDAQ: ACXP
Acurx Pharmaceuticals Inc Stock Ownership - Who owns Acurx Pharmaceuticals?

Insider buying vs selling

Have Acurx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Carl SailerDirector2024-01-1919,737$3.55
$70.07kBuy
Robert J. DelucciaDirector2024-01-0319,737$3.55
$70.07kBuy
David P. LuciPresident and CEO2024-01-0319,737$3.55
$70.07kBuy

1 of 1

ACXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACXP insiders and whales buy or sell their stock.

ACXP Shareholders

What type of owners hold Acurx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
David P. Luci6.93%1,098,280$2.72MInsider
Robert J. Deluccia6.09%964,782$2.39MInsider
Vanguard Group Inc3.10%491,687$1.22MInstitution
Prospect Financial Services LLC1.72%272,850$676.67kInstitution
Robert G. Shawah1.19%189,200$469.22kInsider
Carl Sailer0.74%117,552$291.53kInsider
Geode Capital Management LLC0.73%116,352$288.55kInstitution
Osaic Holdings Inc0.36%57,250$141.98kInstitution
State Street Corp0.27%43,466$107.80kInstitution
Lpl Financial LLC0.25%40,235$99.78kInstitution

1 of 3

ACXP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACXP7.88%15.18%Net Buying
ALGS54.72%45.28%Net Buying
XLO29.79%68.66%Net BuyingNet Buying
FBIO14.72%60.54%Net BuyingNet Buying
LEXX6.90%4.82%Net BuyingNet Buying

Acurx Pharmaceuticals Stock Ownership FAQ

Who owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals (NASDAQ: ACXP) is owned by 7.88% institutional shareholders, 15.18% Acurx Pharmaceuticals insiders, and 76.94% retail investors. David P. Luci is the largest individual Acurx Pharmaceuticals shareholder, owning 1.10M shares representing 6.93% of the company. David P. Luci's Acurx Pharmaceuticals shares are currently valued at $2.67M.

If you're new to stock investing, here's how to buy Acurx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.